Serum Adalimumab Concentration and Clinical Remission in Patients with Crohnʼs Disease
Abstract
BackgroundDrug concentration monitoring may be useful to guide therapeutic adjustments for anti–tumor necrosis factor agents in Crohn's disease. The relationship between serum adalimumab concentrations and clinical outcomes was assessed using data from CLinical Assessment of Adalimumab Safety and Efficacy Studied as Induction Therapy in Crohn's Disease (CLASSIC)...
Paper Details
Title
Serum Adalimumab Concentration and Clinical Remission in Patients with Crohnʼs Disease
Published Date
May 1, 2013
Journal
Volume
19
Issue
6
Pages
1112 - 1122
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History